Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PYXSPyxis Oncology, Inc.

Nasdaq · CIK 0001782223
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts267

Identity from submissions API

NamePyxis Oncology, Inc.
CIK0001782223
TickersPYXS
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN831160910
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(617) 221-9059
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
321 HARRISON AVENUE
BOSTON
MA
02118
MA
Mailing address
321 HARRISON AVENUE
BOSTON
MA
02118
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

362 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K 8-K 7.01,8.01 0001193125-26-467780 001-40881 261572287 34 15443729 1 1
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-001035 005-92951 261563355 34 14790
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003186 005-92951 261561421 34 29117
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000202 005-92951 261555702 34 13275
2026-11-13 8-K 8-K 5.03,5.07 0001193125-26-460698 001-40881 261552787 34 201804 1 1
2026-11-06 4 4 0001193125-26-452175 5427
2026-11-05 10-Q 10-Q 0001193125-26-448612 001-40881 261524851 34 13163639 1 1
2026-11-05 8-K 8-K 2.02 0001193125-26-448604 001-40881 261524841 34 495694 1 1
2026-11-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001390202-26-000019 005-92951 261514629 34 11418
2026-10-21 DEF 14A DEF 14A 0001193125-26-427882 001-40881 261475998 34 851718
2026-10-09 PRE 14A PRE 14A 0001193125-26-419208 001-40881 261453634 34 803868
2026-10-09 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-006818 005-92951 261452487 34 21387
2026-10-09 4/A xslF345X06/ownership.xml 0000919574-26-006815 13444
2026-10-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-113597 005-92951 261439172 34 25231
2026-10-02 4 xslF345X06/ownership.xml 0000919574-26-006609 14891
2026-10-02 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-006608 005-92951 261433526 34 24212
2026-10-01 8-K FORM 8-K 1.01,8.01,9.01 0001437749-26-031767 001-40881 261432587 34 828113 1 1
2026-10-01 424B5 FORM 424B5 0001437749-26-031667 333-291801 261429217 33 747634
2026-09-29 424B5 FORM 424B5 0001437749-26-031480 333-291801 261424586 33 756487
2026-09-29 424B5 FORM 424B5 0001437749-26-031470 333-291801 261424066 33 14025
2026-09-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-385901 001-40881 261366682 34 18030921 1 1
2026-09-08 4 4 0001193125-26-384391 5573
2026-09-08 8-K 8-K 5.02,7.01,9.01 0001193125-26-384386 001-40881 261363398 34 266167 1 1
2026-08-28 424B2 424B2 0001193125-26-372221 333-298461 261332923 33 319912
2026-08-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002786 333-298461 261332655 33 1700
2026-08-20 4 4 0001193125-26-359525 5407
2026-08-20 S-3 S-3 0001193125-26-359246 333-298461 261300256 33 724828 1 1
2026-08-14 4 4 0001193125-26-352206 5794
2026-08-13 10-Q 10-Q 0001193125-26-347913 001-40881 261270094 34 9877532 1 1
2026-08-13 8-K 8-K 2.02 0001193125-26-347911 001-40881 261270093 34 492627 1 1
2026-07-10 3 xslF345X06/ownership.xml 0000919574-26-004386 11799
2026-07-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001796 005-92951 261168809 34 40334
2026-07-02 4 4 0001193125-26-294708 9254
2026-07-02 8-K 8-K 1.01,3.02,7.01 0001193125-26-294613 001-40881 261151601 34 1267736 1 1
2026-07-02 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004255 005-92951 261151235 34 19985
2026-06-30 144 xsl144X01/primary_doc.xml 0001959173-26-004977 001-40881 261140652 33 4335
2026-06-15 8-K 8-K 5.07 0001193125-26-271137 001-40881 261091141 34 171005 1 1
2026-05-14 10-Q 10-Q 0001193125-26-222843 001-40881 26975903 34 9722271 1 1
2026-05-14 8-K 8-K 2.02 0001193125-26-222818 001-40881 26975873 34 446555 1 1
2026-04-30 ARS ARS 0001193125-26-194065 001-40881 26920131 34 12060769
2026-04-30 DEFA14A DEFA14A 0001193125-26-194051 001-40881 26920119 34 2215788
2026-04-30 DEF 14A DEF 14A 0001193125-26-194032 001-40881 26920112 34 1820362
2026-04-30 8-K/A 8-K/A 5.02 0001193125-26-193940 001-40881 26920015 34 160122 1 1
2026-03-25 4 4 0001193125-26-124388 5399
2026-03-25 4 4 0001193125-26-124380 7310
2026-03-25 4 4 0001193125-26-124348 5393
2026-03-25 4 4 0001193125-26-124342 5407
2026-03-25 4 4 0001193125-26-124333 5416
2026-03-25 4 4 0001193125-26-124325 5442
2026-03-25 4 4 0001193125-26-124319 5418
2026-03-25 4 4 0001193125-26-124313 5408
2026-03-25 4 FORM 4 0000905148-26-001434 8427
2026-03-23 S-8 S-8 0001193125-26-119700 333-294526 26782180 33 388852 1 1
2026-03-23 10-K 10-K 0001193125-26-118532 001-40881 26779884 34 74373211 1 1
2026-03-23 8-K 8-K 2.02,7.01 0001193125-26-118525 001-40881 26779876 34 22082402 1 1
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001390202-26-000002 005-92951 26610241 34 11502
2026-02-06 8-K 8-K 9.01 0001193125-26-041169 001-40881 26607648 34 197883 1 1
2026-02-05 4 4 0001193125-26-039951 5301
2025-12-18 8-K 8-K 7.01,8.01 0001193125-25-323704 001-40881 251581270 34 15447346 1 1
2025-12-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003615 333-291801 251560742 33 1700
2025-12-08 CORRESP filename1.htm 0001437749-25-037150 8499
2025-11-26 S-3 FORM S-3 0001437749-25-036389 333-291801 251524790 33 1792812 1 1
2025-11-03 10-Q 10-Q 0001193125-25-261696 001-40881 251442132 34 10111421 1 1
2025-11-03 8-K 8-K 2.02 0001193125-25-261689 001-40881 251442125 34 18625671 1 1
2025-10-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-099264 005-92951 251391752 34 15867
2025-09-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-005781 005-92951 251332838 34 20383
2025-08-14 10-Q 10-Q 0000950170-25-108906 001-40881 251219552 34 12374515 1 1
2025-08-14 8-K 8-K 2.02 0000950170-25-108898 001-40881 251219479 34 18621674 1 1
2025-08-04 8-K 8-K 8.01 0000950170-25-101618 001-40881 251177995 34 156858 1 1
2025-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003255 005-92951 251132433 34 10706
2025-07-03 8-K 8-K 5.02 0000950170-25-093456 001-40881 251103476 34 158500 1 1
2025-07-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-064765 005-92951 251096952 34 15489
2025-06-18 8-K 8-K 5.07 0000950170-25-087907 001-40881 251057193 34 172606 1 1
2025-05-15 10-Q 10-Q 0000950170-25-071996 001-40881 25948744 34 9665916 1 1
2025-05-15 8-K 8-K 2.02,7.01 0000950170-25-071992 001-40881 25948730 34 18589460 1 1
2025-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-045055 005-92951 25917512 34 18542
2025-04-29 DEFA14A DEFA14A 0000950170-25-059575 001-40881 25882702 34 778657
2025-04-29 DEF 14A DEF 14A 0000950170-25-059573 001-40881 25882701 34 3105802
2025-04-21 144 xsl144X01/primary_doc.xml 0001959173-25-002656 001-40881 25853315 33 5535
2025-04-17 144 xsl144X01/primary_doc.xml 0001959173-25-002643 001-40881 25847672 33 4956
2025-04-14 144 xsl144X01/primary_doc.xml 0001959173-25-002600 001-40881 25836072 33 4363
2025-04-02 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-049860 005-92951 25807236 34 9607
2025-04-02 4 4 0000950170-25-048905 5443
2025-04-02 4 4 0000950170-25-048903 5217
2025-04-02 4 4 0000950170-25-048902 5450
2025-04-02 4 4 0000950170-25-048901 5286
2025-04-02 4 4 0000950170-25-048900 5284
2025-04-02 4 4 0000950170-25-048899 5221
2025-04-02 4 4 0000950170-25-048898 5264
2025-04-02 4 4 0000950170-25-048895 5215
2025-04-02 4 4 0000950170-25-048894 5254
2025-04-02 4 4 0000950170-25-048893 5457
2025-04-02 4 4 0000950170-25-048892 5258
2025-03-24 8-K 8-K 7.01,9.01 0000950170-25-043491 001-40881 25762228 34 17095594 1 1
2025-03-18 S-8 S-8 0000950170-25-041315 333-285889 25749160 33 242244
2025-03-18 10-K 10-K 0000950170-25-040771 001-40881 25746533 34 40983567 1 1
2025-03-18 8-K 8-K 2.02,5.02,7.01,9.01 0000950170-25-040767 001-40881 25746512 34 17345972 1 1
2025-02-26 8-K 8-K 8.01 0000950170-25-027330 001-40881 25666170 34 232138 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014027 005-92951 25628069 34 11400
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000884 005-92951 25623563 34 11211
2025-02-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-000665 005-92951 25587832 34 11611
2025-02-04 8-K 8-K 8.01 0000950170-25-012846 001-40881 25585364 34 237485 1 1
2024-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-24-139789 005-92951 241575213 34 8520
2024-12-23 4 4 0000950170-24-139616 5319
2024-12-23 4 4 0000950170-24-139608 5328
2024-12-23 4 4 0000950170-24-139598 5324
2024-12-19 8-K 8-K 8.01,9.01 0000950170-24-138563 001-40881 241564124 34 260784 1 1
2024-12-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-128889 005-92951 241551777 34 19884
2024-11-27 4 4 0000950170-24-131606 6850
2024-11-20 8-K 8-K 7.01,9.01 0000950170-24-129238 001-40881 241480356 34 21366604 1 1
2024-11-12 S-8 S-8 0000950170-24-125555 333-283161 241449121 33 199320
2024-11-12 SC 13G/A LAURION CAPITAL MANAGEMENT LP 0001085146-24-005529 005-92951 241445821 34 46157
2024-11-12 10-Q 10-Q 0000950170-24-124602 001-40881 241443372 34 7984192 1 1
2024-11-12 8-K 8-K 2.02 0000950170-24-124581 001-40881 241443335 34 374762 1 1
2024-11-06 SC 13G/A SC 13G/A 0001104659-24-114823 005-92951 241431643 34 57436
2024-10-23 8-K 8-K 5.07,9.01 0000950170-24-116698 001-40881 241389681 34 173917 1 1
2024-09-25 DEF 14A DEF 14A 0000950170-24-109337 001-40881 241324178 34 3155267
2024-09-13 PRE 14A PRE 14A 0000950170-24-106381 001-40881 241298103 34 1265581
2024-08-14 10-Q 10-Q 0000950170-24-097073 001-40881 241208423 34 7791960 1 1
2024-08-14 8-K 8-K 2.02,9.01 0000950170-24-097054 001-40881 241208257 34 361585 1 1
2024-06-12 8-K 8-K 5.07 0000950170-24-072467 001-40881 241038620 34 177867 1 1
2024-06-10 4 4 0000950170-24-071438 5262
2024-06-10 3 3 0000950170-24-071435 25252
2024-06-10 8-K 8-K 5.02,7.01,9.01 0001193125-24-157911 001-40881 241031490 34 175898 1 1
2024-06-07 4 4 0000950170-24-070833 4618
2024-05-14 10-Q 10-Q 0000950170-24-059099 001-40881 24941503 34 7066073 1 1
2024-05-14 8-K 8-K 2.02,9.01 0000950170-24-059093 001-40881 24941494 34 2022161 1 1
2024-04-26 ARS ARS 0000950170-24-049163 001-40881 24884016 34 7512275
2024-04-26 DEFA14A DEFA14A 0000950170-24-049161 001-40881 24883993 34 2332146
2024-04-26 DEF 14A DEF 14A 0000950170-24-049154 001-40881 24883973 34 3632813
2024-04-04 424B2 FORM 424B2 0001437749-24-010967 333-278282 24821251 33 176179
2024-04-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-03 16:00:00 9999999995-24-000851 333-278282 24821528 33 1706
2024-04-03 SC 13D/A SC 13D/A 0000950170-24-041264 005-92951 24819950 34 59552
2024-04-01 CORRESP filename1.htm 0000950170-24-039387 16409
2024-03-29 UPLOAD filename1.pdf 0000000000-24-003389 333-278282 40226
2024-03-28 4 4 0000950170-24-038108 4829
2024-03-28 4 4 0000950170-24-038106 5455
2024-03-28 4 4 0000950170-24-038104 4663
2024-03-28 4 4 0000950170-24-038105 4626
2024-03-28 4 4 0000950170-24-038103 4686
2024-03-28 4 4 0000950170-24-038102 4668
2024-03-28 4 4 0000950170-24-038099 4687
2024-03-28 4 4 0000950170-24-038098 5261
2024-03-28 4 4 0000950170-24-038097 4824
2024-03-27 S-3 FORM S-3 0001437749-24-009629 333-278282 24791785 33 373749
2024-03-27 8-K 8-K 8.01,9.01 0000950170-24-037176 001-40881 24790698 34 348368 1 1
2024-03-27 8-K 8-K 8.01,9.01 0000950170-24-036822 001-40881 24785813 34 188093 1 1
2024-03-22 S-8 S-8 0000950170-24-034898 333-278159 24772539 33 203526
2024-03-21 10-K 10-K 0000950170-24-034868 001-40881 24772273 34 17879956 1 1
2024-03-21 8-K 8-K 2.02,7.01,9.01 0000950170-24-034427 001-40881 24769474 34 21819110 1 1
2024-03-13 4 4 0000950170-24-030865 5260
2024-03-13 3 3 0000950170-24-030842 16263
2024-03-13 8-K 8-K 5.02,7.01,9.01 0000950170-24-030817 001-40881 24746380 34 190761 1 1
2024-03-08 SC 13G deeptrack-pyxs022724.htm 0001172661-24-001677 005-92951 24734251 34 102901
2024-02-28 8-K 8-K 1.01,3.02,7.01,9.01 0000950170-24-021643 001-40881 24690127 34 1191870 1 1
2024-02-14 SC 13G/A AMENDMENT NO. 2 0001214659-24-002875 005-92951 24637364 34 83334
2024-02-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-000436 005-92951 24633103 34 266012
2024-01-26 SC 13G SC 13G 0001104659-24-007297 005-92951 24568435 34 81101
2023-12-29 4 FORM 4 SUBMISSION 0001209191-23-060006 7901
2023-12-06 3 FORM 3 SUBMISSION 0001209191-23-057631 6645
2023-11-30 4 FORM 4 SUBMISSION 0001209191-23-056969 4745
2023-11-28 8-K 8-K 5.02,9.01 0000950170-23-066245 001-40881 231441892 34 332435 1 1
2023-11-17 4 FORM 4 SUBMISSION 0001209191-23-055744 4795
2023-11-07 10-Q 10-Q 0000950170-23-060354 001-40881 231384750 34 9872282 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-060352 001-40881 231384699 34 412515 1 1
2023-10-27 8-K/A 8-K/A 9.01 0000950170-23-056026 001-40881 231356005 34 4054733 1 1
2023-09-28 4 FORM 4 SUBMISSION 0001209191-23-050734 4760
2023-09-27 4 FORM 4 SUBMISSION 0001209191-23-050686 4753
2023-09-27 4 FORM 4 SUBMISSION 0001209191-23-050685 5088
2023-09-26 4 FORM 4 SUBMISSION 0001209191-23-050613 5367
2023-09-25 4 FORM 4 SUBMISSION 0001209191-23-050495 4753
2023-09-25 4 FORM 4 SUBMISSION 0001209191-23-050492 5090
2023-09-22 4 FORM 4 SUBMISSION 0001209191-23-050433 4757
2023-09-22 4 FORM 4 SUBMISSION 0001209191-23-050432 4762
2023-09-18 4 FORM 4 SUBMISSION 0001209191-23-049826 6072
2023-09-18 144 xsl144X01/primary_doc.xml 0001959173-23-003986 001-40881 231261476 33 6552
2023-09-14 144 xsl144X01/primary_doc.xml 0001959173-23-003945 001-40881 231255618 33 5968
2023-09-13 4 FORM 4 SUBMISSION 0001209191-23-049366 10421
2023-09-13 144 xsl144X01/primary_doc.xml 0001959173-23-003923 001-40881 231253224 33 5390
2023-09-12 144 xsl144X01/primary_doc.xml 0001959173-23-003903 001-40881 231250567 33 4819
2023-09-11 144 xsl144X01/primary_doc.xml 0001959173-23-003883 001-40881 231248289 33 4234
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048819 4705
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048816 4697
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048814 4691
2023-09-06 UPLOAD filename1.pdf 0000000000-23-009852 39648
2023-09-05 144 xsl144X01/primary_doc.xml 0001959173-23-003756 001-40881 231236800 33 9920
2023-08-28 CORRESP filename1.htm 0000950170-23-044862 51853
2023-08-25 4 FORM 4 SUBMISSION 0001209191-23-047384 10641
2023-08-25 3 FORM 3 SUBMISSION 0001209191-23-047383 6592
2023-08-24 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001437749-23-024546,2023-08-24 9999999995-23-002487 333-272510 231203717 33 1671
2023-08-23 S-8 POS FORM S-8 POS 0001437749-23-024548 333-272510 231198433 33 409132
2023-08-23 POS AM FORM POS AM 0001437749-23-024546 333-272510 231198414 33 913815
2023-08-23 S-8 FORM S-8 0001437749-23-024545 333-274178 231198412 33 225176
2023-08-23 8-K 8-K 2.01,5.02,7.01,9.01 0000950170-23-044036 001-40881 231195353 34 246745 1 1
2023-08-16 UPLOAD filename1.pdf 0000000000-23-008916 43203
2023-08-11 144 xsl144X01/primary_doc.xml 0001959173-23-003168 001-40881 231164995 33 8809
2023-08-11 10-Q 10-Q 0000950170-23-041605 001-40881 231161530 34 8962059 1 1
2023-08-11 425 425 0000950170-23-041602 333029
2023-08-11 8-K 8-K 2.02,9.01 0000950170-23-041601 001-40881 231161512 34 462223 1 1
2023-08-11 425 425 0000950170-23-041579 1078206
2023-08-11 8-K 8-K 8.01,9.01 0000950170-23-041578 001-40881 231161441 34 1237018 1 1
2023-08-01 144 xsl144X01/primary_doc.xml 0001959173-23-002778 001-40881 231132762 33 8767
2023-07-31 144 xsl144X01/primary_doc.xml 0001959173-23-002717 001-40881 231127913 33 7660
2023-07-28 144/A xsl144X01/primary_doc.xml 0001959173-23-002663 001-40881 231120672 33 7295
2023-07-27 144 xsl144X01/primary_doc.xml 0001959173-23-002659 001-40881 231119288 33 8684
2023-07-21 144 xsl144X01/primary_doc.xml 0001959173-23-002566 001-40881 231102807 33 6495
2023-07-11 144 xsl144X01/primary_doc.xml 0001959173-23-002338 001-40881 231081779 33 5898
2023-06-30 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-06-30 15:00:00 9999999995-23-001957 333-272510 231063443 33 1658
2023-06-30 425 425 0000950170-23-031134 60800
2023-06-30 8-K 8-K 5.02 0000950170-23-031128 001-40881 231062186 34 191615 1 1
2023-06-30 424B3 FORM 424B3 0001437749-23-019027 333-272510 231061690 33 5218722
2023-06-29 CORRESP filename1.htm 0001437749-23-018918 8794
2023-06-29 S-4/A FORM S-4/A 0001437749-23-018898 333-272510 231057468 33 17545514 1 1
2023-06-16 144 xsl144X01/primary_doc.xml 0001959173-23-001971 001-40881 231020701 33 5308
2023-06-15 UPLOAD filename1.pdf 0000000000-23-006475 40125
2023-06-13 8-K 8-K 5.07 0000950170-23-027742 001-40881 231011954 34 203794 1 1
2023-06-08 144 xsl144X01/primary_doc.xml 0001959173-23-001717 001-40881 231001834 33 5286
2023-06-08 S-4 FORM S-4 0001437749-23-016930 333-272510 231000758 33 17616863 1 1
2023-06-07 144 xsl144X01/primary_doc.xml 0001959173-23-001686 001-40881 231000314 33 4693
2023-05-30 425 425 0000950170-23-024900 001-40881 23977142 34 49635
2023-05-25 425 425 0000950170-23-024070 142437
2023-05-24 425 425 0000950170-23-023958 24551
2023-05-24 425 425 0000950170-23-023950 19089138
2023-05-24 8-K 8-K 7.01,9.01 0000950170-23-023946 001-40881 23954878 34 19237297 1 1
2023-05-24 425 425 0001193125-23-152390 001-40881 23950578 34 636484
2023-05-24 425 425 0000950170-23-023756 001-40881 23950573 34 1606775
2023-05-24 8-K 8-K 1.01,5.02,7.01,8.01,9.01 0000950170-23-023753 001-40881 23950557 34 1908420 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020836 001-40881 23908809 34 7715446 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020833 001-40881 23908799 34 397337 1 1
2023-05-10 10-K/A 10-K/A 0000950170-23-020611 001-40881 23907129 34 2023853 1 1
2023-04-28 ARS ARS 0000950170-23-015881 001-40881 23867131 34 15005133
2023-04-28 DEFA14A DEFA14A 0000950170-23-015869 001-40881 23866952 34 263074
2023-04-28 DEF 14A DEF 14A 0000950170-23-015858 001-40881 23866885 34 1629175
2023-04-04 SC 13D/A SC 13D/A 0000950170-23-011796 005-92951 23798904 34 79454
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021415 14893
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021413 14882
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021412 14943
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021411 12020
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021409 4781
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021408 4781
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021407 4758
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021405 4724
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021404 5671
2023-03-28 8-K 8-K 5.02 0000950170-23-010318 001-40881 23770044 34 185755 1 1
2023-03-23 SC 13G/A SC 13G A 2 PYXIS ONCOLOGY 0000078003-23-000053 005-92951 23756501 34 76962
2023-03-23 4/A PRIMARY DOCUMENT 0000078003-23-000052 7266
2023-03-22 S-8 S-8 0000950170-23-009209 333-270753 23753404 33 258176
2023-03-22 10-K 10-K 0000950170-23-009046 001-40881 23751286 34 18143477 1 1
2023-03-22 8-K 8-K 2.02,5.02 0000950170-23-009044 001-40881 23751253 34 414601 1 1
2023-03-21 4 PRIMARY DOCUMENT 0000078003-23-000050 7059
2023-03-16 8-K 8-K 7.01,9.01 0000950170-23-008307 001-40881 23737167 34 218310 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021802 005-92951 23630730 34 86071
2023-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-23-002402 005-92951 23628410 34 82257
2023-02-14 SC 13G/A PYXIS ONCOLOGY, INC. 0000902664-23-001702 005-92951 23623767 34 61762
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000475 005-92951 23620646 34 276614
2023-02-13 SC 13G/A SC 13G/A PYXIS ONCOLOGY 0000078003-23-000013 005-92951 23619902 34 74352
2023-02-08 SC 13G laurion-pyxs123122.htm 0001172661-23-000538 005-92951 23600086 34 101105
2023-01-03 4 FORM 4 0001567619-23-000068 4704
2023-01-03 4 FORM 4 0001567619-23-000067 4679
2023-01-03 4 FORM 4 0001567619-23-000066 4635
2022-12-01 8-K 8-K 8.01,9.01 0000950170-22-025912 001-40881 221437284 34 219213 1 1
2022-11-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-14 16:00:00 9999999995-22-003295 333-268100 221389186 33 1672
2022-11-10 CORRESP filename1.htm 0001193125-22-282411 6557
2022-11-04 SC 13G p111223sc13g.htm 0001214659-22-013148 005-92951 221362218 34 90688
2022-11-03 UPLOAD filename1.pdf 0000000000-22-011981 40081
2022-11-01 S-3 S-3 0001193125-22-275013 333-268100 221351170 33 1057005
2022-11-01 10-Q 10-Q 0000950170-22-020701 001-40881 221348506 34 9149954 1 1
2022-11-01 8-K 8-K 2.02,9.01 0000950170-22-020699 001-40881 221348480 34 453388 1 1
2022-10-13 3 PRIMARY DOCUMENT 0000078003-22-000095 6044
2022-10-07 8-K 8-K 1.01,3.02 0001193125-22-259636 001-40881 221301088 34 146637 1 1
2022-08-15 4 FORM 4 0001140361-22-029677 4968
2022-08-15 3 FORM 3 0001140361-22-029665 11906
2022-08-15 10-Q 10-Q 0000950170-22-017222 001-40881 221162304 34 7531900 1 1
2022-08-15 8-K 8-K 2.02,5.02,9.01 0000950170-22-017220 001-40881 221162294 34 444709 1 1
2022-08-09 3 FORM 3 0001567619-22-015316 15157
2022-08-09 8-K 8-K 5.02 0000950170-22-016063 001-40881 221148448 34 170474 1 1
2022-07-01 S-8 S-8 0001193125-22-187297 333-266005 221062247 33 86278
2022-06-14 8-K 8-K 5.07 0001193125-22-173861 001-40881 221015232 34 149401 1 1
2022-05-23 SC 13D/A SC 13D/A 0001140361-22-020157 005-92951 22949531 34 48949
2022-05-13 10-Q 10-Q 0000950170-22-009807 001-40881 22920340 34 6874516 1 1
2022-05-13 8-K 8-K 2.02,9.01 0000950170-22-009803 001-40881 22920324 34 352977 1 1
2022-04-28 DEFA14A DEFA14A 0001193125-22-127730 001-40881 22867303 34 530158
2022-04-28 DEF 14A DEF 14A 0001193125-22-127710 001-40881 22867239 34 1418761
2022-04-27 4 PRIMARY DOCUMENT 0000312069-22-000068 3996
2022-04-26 3 PRIMARY DOCUMENT 0000312069-22-000067 5364
2022-04-25 4 FORM 4 SUBMISSION 0000899243-22-015542 5043
2022-04-15 4 FORM 4 0001567619-22-008615 4983
2022-04-15 4 FORM 4 0001567619-22-008614 5028
2022-04-15 4 FORM 4 0001567619-22-008613 5359
2022-04-14 8-K 8-K 5.02,8.01,9.01 0001193125-22-105729 001-40881 22828173 34 176705 1 1
2022-04-04 4 FORM 4 0001140361-22-012921 4351
2022-04-04 4 FORM 4 0001140361-22-012918 4540
2022-04-04 4 FORM 4 0001140361-22-012924 4607
2022-04-04 4 FORM 4 0001140361-22-012919 5263
2022-04-04 4 FORM 4 0001140361-22-012917 5534
2022-04-04 4 FORM 4 0001140361-22-012914 4316
2022-04-04 4 FORM 4 0001140361-22-012916 4496
2022-04-04 4 FORM 4 0001140361-22-012913 4373
2022-03-29 S-8 S-8 0001193125-22-088207 333-263950 22781614 33 66406
2022-03-29 10-K 10-K 0000950170-22-004850 001-40881 22777379 34 18726451 1 1
2022-03-29 8-K 8-K 2.02,8.01,9.01 0000950170-22-004848 001-40881 22777372 34 375385 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022766 005-92951 22631947 34 86530
2022-02-14 SC 13G PYXIS ONCOLOGY, INC. 0000902664-22-001604 005-92951 22625776 34 66250
2022-02-11 SC 13G SC 13G 0001104659-22-020578 005-92951 22621766 34 63060
2022-02-11 SC 13G SC 13G PYXIS ONCOLOGY 0000078003-22-000010 005-92951 22621511 34 76714
2021-12-20 SC 13G THE SCHEDULE 13G 0000921895-21-002880 005-92951 211506150 34 285450
2021-12-09 4 FORM 4 SUBMISSION 0000899243-21-047525 4954
2021-12-07 4 FORM 4 SUBMISSION 0000899243-21-047102 5364
2021-11-19 4 FORM 4 SUBMISSION 0000899243-21-045363 5332
2021-11-15 10-Q 10-Q 0000950170-21-004476 001-40881 211406399 34 8235816 1 1
2021-11-15 8-K 8-K 2.02,9.01 0000950170-21-004462 001-40881 211406364 34 409903 1 1
2021-10-25 SC 13G SC 13G 0001104659-21-129526 005-92951 211344526 34 80578
2021-10-22 S-8 S-8 0001193125-21-305462 333-260441 211340820 33 352681
2021-10-22 SC 13D efc21-572_sc13d.htm 0000905148-21-000683 005-92951 211338225 34 59054
2021-10-15 4 FORM 4 0001140361-21-034645 8947
2021-10-15 4 FORM 4 0001140361-21-034643 6868
2021-10-15 4 PRIMARY DOCUMENT 0001578563-21-000038 11648
2021-10-15 4 FORM 4 0001567619-21-018355 15900
2021-10-12 4 FORM 4 0001140361-21-034427 5059
2021-10-12 4 FORM 4 0001140361-21-034426 5063
2021-10-12 4 FORM 4 0001140361-21-034425 5029
2021-10-12 4 FORM 4 0001140361-21-034424 6849
2021-10-12 4 FORM 4 0001140361-21-034423 5016
2021-10-12 4 FORM 4 0001140361-21-034422 5086
2021-10-12 4 FORM 4 0001140361-21-034421 5305
2021-10-12 4 FORM 4 0001140361-21-034420 5072
2021-10-12 4 FORM 4 0001140361-21-034419 5063
2021-10-08 424B4 424B4 0001193125-21-295600 333-259627 211315906 33 6186228
2021-10-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-10-07 16:00:00 9999999995-21-003820 333-259627 211313738 33 1706
2021-10-07 S-1MEF S-1MEF 0001193125-21-294497 333-260127 211313721 33 54877
2021-10-07 3 FORM 3 0001140361-21-034083 16469
2021-10-07 3 FORM 3 0001140361-21-034081 15395
2021-10-07 3 FORM 3 0001140361-21-034079 16466
2021-10-07 3 FORM 3 0001140361-21-034077 16327
2021-10-07 3 PRIMARY DOCUMENT 0001578563-21-000036 8202
2021-10-07 3 FORM 3 0001140361-21-034075 15492
2021-10-07 3 FORM 3 0001140361-21-034072 14077
2021-10-07 3 FORM 3 0001140361-21-034070 15359
2021-10-07 3 FORM 3 0001140361-21-034068 14144
2021-10-07 3 FORM 3 0001140361-21-034066 14097
2021-10-07 3 FORM 3 0001140361-21-034063 16104
2021-10-07 SEC STAFF LETTER filename1.pdf 9999999997-21-005189 394706
2021-10-07 3 FORM 3 0001567619-21-018043 11327
2021-10-07 S-1/A S-1/A 0001193125-21-293655 333-259627 211311009 33 6291962
2021-10-06 CERT 8A_CERT_PYXS.pdf 0001354457-21-001130 001-40881 211309072 34 250042
2021-10-05 8-A12B 8-A12B 0001193125-21-292187 001-40881 211307366 34 13321
2021-10-05 CORRESP filename1.htm 0001193125-21-292066 14487
2021-10-05 CORRESP filename1.htm 0001193125-21-292052 8723
2021-10-04 S-1/A S-1/A 0001193125-21-290298 333-259627 211300943 33 7676412
2021-10-01 S-1/A S-1/A 0001193125-21-288350 333-259627 211296627 33 1253852
2021-09-28 CORRESP filename1.htm 0001193125-21-285776 92196
2021-09-17 S-1 S-1 0001193125-21-276227 333-259627 211261130 33 7088109
2021-09-17 SEC STAFF LETTER filename1.pdf 9999999997-21-004807 400469
2021-09-10 DRS/A filename1.htm 0000950123-21-012245 377-05065 211245712 33 7046199
2021-09-09 DRSLTR filename1.htm 0000950123-21-012246 17774
2021-08-18 UPLOAD filename1.pdf 0000000000-21-010164 44665
2021-08-04 DRSLTR filename1.htm 0000950123-21-009657 39383
2021-08-04 DRS/A filename1.htm 0000950123-21-009656 377-05065 211145184 33 6149819
2021-07-16 UPLOAD filename1.pdf 0000000000-21-008827 57774
2021-06-21 DRS filename1.htm 0000950123-21-008029 377-05065 211031385 33 5742171
2021-03-22 D xslFormDX01/primary_doc.xml 06b 0001782223-21-000002 021-393076 21761959 33 11187
2019-07-12 D xslFormDX01/primary_doc.xml 06b 0001782223-19-000001 021-344177 19952811 33 10067

Latest XBRL company facts

One latest value per concept from companyfacts (267 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 119.61M 2026-11-04 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
dei EntityPublicFloat Entity Public Float USD 64.40M 2025-06-30 2025 FY 10-K 2026-03-23 0001193125-26-118532
ffd NetFeeAmt NetFeeAmt USD 17,756.48 2026-08-20 S-3 2026-08-20 0001193125-26-359246
ffd TtlFeeAmt TtlFeeAmt USD 17,756.48 2026-08-20 S-3 2026-08-20 0001193125-26-359246
ffd TtlOfferingAmt TtlOfferingAmt USD 128.58M 2026-08-20 S-3 2026-08-20 0001193125-26-359246
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-20 S-3 2026-08-20 0001193125-26-359246
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-20 S-3 2026-08-20 0001193125-26-359246
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 8.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3.00M 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108906
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 771,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 9.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 810,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.01M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -56,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 553.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 39.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 17,729 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap Assets Assets USD 76.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AssetsCurrent Assets, Current USD 59.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2022-09-30 2022 Q3 10-Q 2022-11-01 0000950170-22-020701
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 53,000 2025-12-31 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 56,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 51.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 51.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 1.30M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060354
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 31.64M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 6.66M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 519,000 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable USD 4.55M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue USD 6.66M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities USD 2.16M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 24.46M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 20.91M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 10.73M 2023-08-23 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 237,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 200.00M 2021-10-08 2021 FY 10-K 2022-03-29 0000950170-22-004850
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 6.66M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 55.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 5.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -11.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 42.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 190.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 83.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 83.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CommonStockValue Common Stock, Value, Issued USD 83,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -68.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 7.66M 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap CostOfRevenue Cost of Revenue USD 2.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 300,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 1.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 53,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2024-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 8,000 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 41.70M 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 3.50M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004476
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.00M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 1.10M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004476
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 2.03M 2023-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 1.07M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 49,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 154.58M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 2.16M 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034868
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.00M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 96.34M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 276,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 12.87M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 3.61M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 796,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 151.59M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap Depreciation Depreciation USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -6.23M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 9.12M 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004476
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 67,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004476
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.97 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0000950170-22-009807
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.205 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.024 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.024 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.017 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.32M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 12.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 514,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.49M 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 223,000 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 223,000 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 223,000 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 223,000 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 223,000 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 2.60M 2024-12-31 2024 FY 10-K 2025-03-18 0000950170-25-040771
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 18.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -68.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap IncomeTaxesPaid Income Taxes Paid USD 48,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034868
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -169,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 42,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -2.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-347913
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -7.66M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -2.16M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 3.37M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-01 0000950170-22-020701
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 340,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020836
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 23,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 2.90M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 0 2022-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034868
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 91,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 21,000 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034868
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 480,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap InvestmentIncomeNet Investment Income, Net USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 771,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap LeaseCost Lease, Cost USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 25.81M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 7.92M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.38M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.79M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.68M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.58M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.47M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.50M 2023-02-02 2023 Q3 10-Q 2023-11-07 0000950170-23-060354
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 7.16M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap Liabilities Liabilities USD 35.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 76.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap LiabilitiesCurrent Liabilities, Current USD 19.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2022-09-30 2022 Q3 10-Q 2022-11-01 0000950170-22-020701
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 51.72M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -109,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 48.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 380,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -60.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -68.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124602
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingExpenses Operating Expenses USD 70.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -70.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 714,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 18.65M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 15.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 10.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 700,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020836
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.094 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 431,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap OtherAssetsCurrent Other Assets, Current USD 626,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 109,000 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -109,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.45M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-01 0000950170-22-020701
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 113,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 63.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 50,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.78M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PrepaidInsurance Prepaid Insurance USD 586,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 152.30M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 3,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004850
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 151.58M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 48.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 322,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -68.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 15.00M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 6.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 52.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 20.00M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-01 0000950170-22-020701
us-gaap RestrictedCash Restricted Cash USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 2.94M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017222
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -35,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -511.78M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap Revenues Revenues USD 13.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 265,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 14.50M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034868
us-gaap SecurityDeposit Security Deposit USD 400,000 2023-12-31 2023 FY 10-K 2024-03-21 0000950170-24-034868
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 8.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 117,849 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 143,708 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 968,512 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 2.83 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 196,164 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0.05 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.997 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-347913
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.971 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-347913
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.046 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 5.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 11.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.23 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 8,668 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 445,435 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 9.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 18.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.54 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 5,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0000950170-22-004850
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 1.62 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.47 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 21,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-222843
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 41.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.157 2021-10-01 2021 FY 10-K 2022-03-29 0000950170-22-004850
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 206,384 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 194.02M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 108,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 48.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD -393,000 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124602
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 322,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap SubleaseIncome Sublease Income USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -6.23M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009046
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.00M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 11.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-118532
us-gaap VariableLeaseCost Variable Lease, Cost USD 910,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 70.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 32.32M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0000950170-22-009807
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 70.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448612

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →